Apellis Pharmaceuticals, Inc. (APLS)
25.15
-0.09
(-0.36%)
USD |
NASDAQ |
Dec 31, 10:57
Apellis Pharmaceuticals Price: 25.15 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 175.20 |
| Amicus Therapeutics, Inc. | 14.26 |
| Fortress Biotech, Inc. | 3.66 |
| Ultragenyx Pharmaceutical, Inc. | 22.57 |
| Fulcrum Therapeutics, Inc. | 11.42 |
Price Related Metrics
| PE Ratio | 84.68 |
| PS Ratio | 3.131 |
| Price to Book Value | 7.932 |
| Price to Free Cash Flow | 40.46 |
| Earnings Yield | 1.18% |
| Market Cap | 3.182B |
| Operating PE Ratio | 39.57 |
| Normalized PE Ratio | 84.68 |